October 08, 2009 09:35 ET

Market Watch: Sunwin International Neutraceuticals -- October 8, 2009

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Stock Market Alerts LLC.

MIAMI, FL--(Marketwire - October 8, 2009) - Stock Market Alert's performance stock list includes: Sunwin International Neutraceuticals, Inc. (OTCBB: SUWN), Vonage (NYSE: VG), and Marvell (NASDAQ: MRVL).

Sunwin International Neutraceuticals, Inc. (OTCBB: SUWN) has just announced it has signed an exclusive distribution agreement with Hunan Fuhui Flavors Co. Ltd. to distribute Sunwin's stevia extract within Hunan province in China. The company is one of the world's leading producers of all-natural, zero-calorie stevia in China and a leader in the production and distribution of Chinese herbs and veterinary medicines.

The press release states that under the terms of the one year agreement, Sunwin will provide marketing support and technical staff to support Hunan Fuhui's sales efforts within the province. Additionally, Hunan Fuihui must distribute at least 50 tons of stevia extract within the first year for this agreement to be subject to renewal. Hunan Fuhui is an experienced distributor based in the Hunan province, located in southern China and home to more than 64 million people.

Commenting on the agreement, Chairman Laiwang Zhang stated, "We are pleased to secure a strong partner in Hunan Fuhui, whose expertise as a regional distributor makes them an ideal candidate to increase Sunwin's presence in Hunan province where stevia is commonly used as a natural sweetener. We have recently completed a number of expansion programs to increase our total stevia production capacity and we are particularly excited to expand our marketing efforts in this important domestic market. We look forward to this new partnership as we continue pursue opportunities both in China and throughout the globe to expand revenue and profits in our stevia operations."

The company also reported last month that has completed the conversion of Qufu Shengren's production facilities to produce high grade stevia. The newly converted facilities add 250 metric tons of production capacity for high grade stevia extract up to rebaudioside A 98, bringing Sunwin's total high grade stevia annual production capacity to 500 metric tons.

Qufu Shengren, founded in December 2003, manufactured and distributed pharmaceutical products throughout China. In March 2007, Qufu Shengren received a Certificate of Good Manufacturing Practices ("GMP Certificate") from State Food and Drug Administration in China for its pharmaceutical products. In April 2009, Sunwin International acquired 100% interest of Qufu Shengren and began the conversion of the facilities to produce high grade stevia extracts. The completion of this conversion comes at a time when Sunwin is poised to enter its stevia extracts for use as a sweetener in the U.S. food and beverage industry with the completion of the process for U.S. Food and Drug Administration ("FDA") self-affirmed GRAS status for stevia extracts produced by Sunwin.

The stock closed yesterday at around Twenty Three cents a share a share.

For an in-depth profile of Sunwin International Neutraceuticals, visit http://wallstreetenews.com/view-company-profiles.php?profile=SUWN_072909.

Vonage (NYSE: VG) up 38.8% on 95.5 million shares traded. Vonage is a software technology company that enables high-quality voice and messaging services across multiple devices and locations over broadband networks.

Marvell (NASDAQ: MRVL) down 2.3% on 11.1 million shares traded. Marvell is a world leader in the development of storage, communications, and consumer silicon solutions. The company's diverse product portfolio includes switching, transceiver, communications controller, wireless, and storage solutions that power the entire communications infrastructure including enterprise, metro, home, and storage networking.

This advertisement is provided by Wall Street Enews, a division of Stock Market Alerts LLC, an electronic broadcaster and publisher of this release, and hereafter referred to as "the company". The company also maintains a contractual, working relationship with Wall Street Capital Funding LLC. and its' Wall Street News Alert brand. For current services performed for Sunwin International Neutraceuticals, Inc. (OTCBB: SUWN), China Direct Industries, Inc. ("China Direct Industries"), Dragon Capital Group Corp, China America Holdings, China Armco Metals, Inc. and Dragon International Group Corp., the company has been compensated a total of Three Hundred Thousand Dollars (Two Hundred and Fifty Thousand dollars for current services and Fifty Thousand dollars for previous services) by China Direct Investments Inc., a Florida corporation, and a wholly owned subsidiary of China Direct. The company does not hold any shares of the stock. Because the company received compensation for its services, there is an inherent conflict of interest in the company statements and opinions and such statements and opinions cannot be considered independent.

The information contained in this press release is for informational purposes only, and not to be construed as an offer to sell or solicitation of an offer to buy any security. The company makes no representation or warranty relating to the validity of the facts presented nor does the company represent or warrant that all material facts necessary to make an investment decision are presented above. Stock Market Alerts LLC is an advertising company and therefore, this release should be viewed for informational purposes only.

The company relies exclusively on information gathered on the public company, such as public filings, press releases and its web sites. Investors should use the advertising information contained in this release as a starting point for conducting additional research on the public company in order to allow the investor to form his or her own opinion regarding the public company. Factual statements contained in this publication are made as of the date stated and they are subject to change without notice. The company is not a registered investment adviser, broker or a dealer.

Investing in the public company that this release is providing service for should be reviewed as speculative and a high-risk and may result in the loss of some or all of any investment.

This release may contain statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend," and similar expressions and variations thereof are intended to identify forward-looking statements.